Whittaker Talc Settlement: Judge Approves $535M Brenntag-Berkshire Deal Over Victims' Objections

A federal bankruptcy judge in New Jersey approved the $535 million Whittaker talc settlement on Thursday, October 22, 2026, ruling that the deal between bankrupt talc supplier Whittaker, Clark & Daniels and its former corporate affiliates, chemical distributor Brenntag and Berkshire Hathaway's National Indemnity Co., is fair and reasonable. The ruling extinguishes successor liability claims that asbestos-talc claimants wanted to press against those solvent companies themselves, and a lawyer for the claimants has said she will appeal.

Chief Judge Michael B. Kaplan overruled the objections of the Official Committee of Talc Claimants and denied the committee's joint motion with the future claimants' representative for standing to sue Brenntag and its affiliates directly, according to Reuters. Law360 reported that the same order approved a separate environmental settlement in the case. For the asbestos and talc plaintiffs' bar, the result is a working demonstration of how a defunct supplier can use Chapter 11 to settle, for a fixed sum, claims that victims believed were worth far more against a deep-pocketed successor.

What is the Whittaker talc settlement?

The Whittaker talc settlement is a $535 million agreement under which Brenntag, DB US Holding Corp. and certain Berkshire Hathaway entities pay the Whittaker bankruptcy estate in exchange for releases of the estate's claims against them, chiefly the successor liability claims that talc victims had been asserting against Brenntag in state courts. Whittaker asked the bankruptcy court to approve the deal in 2024, and the dispute over it has run through the bankruptcy court, the Third Circuit and, most recently, the U.S. Supreme Court's certiorari docket.

Whittaker, Clark & Daniels was for decades one of the largest suppliers of cosmetic talc in the United States. Its talc ended up in body powders and cosmetics, and before bankruptcy it was a regular defendant in mesothelioma trials. A Los Angeles jury returned an $18.07 million verdict in the Depoian case in 2016, assigning Whittaker 30 percent of the fault; a New York appellate court affirmed a $6.6 million verdict against it in Nemeth; another Los Angeles jury awarded $4.8 million in 2021 to a Vietnam veteran who used Old Spice talc; and a South Carolina jury ordered Whittaker to pay $29.14 million to a woman with mesothelioma in the 2023 Plant trial.

On April 26, 2023, Whittaker and three affiliates, including Soco West, Inc., filed voluntary Chapter 11 petitions in the District of New Jersey (Case No. 23-13575). By then the company faced more than 2,700 claims alleging that its talc was contaminated with asbestos. Whittaker no longer operated a business; its value to creditors lay almost entirely in its insurance and in claims it held against other companies.

How much is the Whittaker talc settlement and who is paying it?

The settlement is worth $535 million, paid by Whittaker's former affiliates: Brenntag (and related entities, including DB US Holding Corp.) and companies in the Berkshire Hathaway group, led by National Indemnity Company. The money goes to the Whittaker estate, not directly to individual claimants, and it is meant to fund the estate's payments to talc and other creditors under a Chapter 11 plan.

The reason those particular companies are paying traces back two decades:

Party	Role in the case	Relationship to Whittaker
Whittaker, Clark & Daniels, Inc. and three affiliates	Chapter 11 debtors (Bankr. D.N.J. No. 23-13575)	Former cosmetic talc supplier; sold its operating assets in 2004
Brenntag (North America)	Settling party; target of successor liability suits	Bought Whittaker's operating assets in 2004 for $200 million without assuming asbestos or environmental liabilities
National Indemnity Co. (Berkshire Hathaway)	Settling party	Acquired Brenntag's stock ownership of the debtors in 2007; through a chain of indemnity agreements, backstops asbestos successor liability claims against Brenntag
DB US Holding Corp.	Settling party	Former corporate affiliate named in the settlement
Official Committee of Talc Claimants and future claimants' representative	Objectors	Represent current and future asbestos-talc claimants
U.S. EPA, California and Montana	Parties to a separate environmental settlement	Hold environmental claims tied to the debtors, including the Lockwood Solvent Superfund site

According to the Third Circuit's opinion, in the 2004 transaction Whittaker and two affiliates sold their operating assets to Brenntag for $200 million; Brenntag did not assume the sellers' asbestos and environmental liabilities, and the sellers agreed to indemnify Brenntag for them. When National Indemnity acquired the debtors in 2007, it took on, through indemnities, the economic risk of asbestos successor claims against Brenntag. That chain is why a Berkshire insurer, and not just Brenntag, sits at the center of the deal.

Why did talc victims object to the Whittaker settlement?

Talc victims objected because they believe the successor liability claims against Brenntag are worth much more than $535 million and should belong to them, not to Whittaker's estate. Several states, including New Jersey and California, recognize a "product-line" theory of successor liability, under which a company that buys a manufacturer's product line and continues it can be liable for injuries caused by the predecessor's products. Before bankruptcy, claimants pursued Brenntag on exactly that theory.

The Official Committee of Talc Claimants called the deal "a smack in the face" to claimants and an insider-negotiated settlement, Law360 reported during the approval fight. Law360's report on the approval described the released successor claims as ones "some estimated to be worth billions." Claimants also argued the deal improperly shields solvent former affiliates that never filed for bankruptcy.

The federal government objected too. In early 2025 the EPA argued that the settlement rested on an undervaluation of the debtors' environmental liabilities. That objection was resolved through a separate environmental settlement, described below.

Judge Kaplan rejected the claimants' objections. Reuters reported that he found the deal fair and reasonable based on his assessment of the estate's litigation claims and the claimants' prospects of obtaining judgments against Whittaker's former corporate parents, the standard test for approving a compromise of estate claims. He also held, as The Legal Circle reported, that the indemnification and contribution claims at issue belong to the debtor.

Ownership versus value: the two questions behind the ruling

The approval turned on two distinct questions that commentators and objectors have sometimes merged.

The first is who owns the claims. If successor liability claims against Brenntag belong to the estate, only the debtor (or a party the court authorizes) can sue on them or settle them, and individual claimants are bound by that settlement. If they belong to individual claimants, Whittaker could not release them without the claimants' consent, and a nonconsensual third-party release would run into the Supreme Court's 2024 decision in Harrington v. Purdue Pharma. The Third Circuit answered the ownership question in the estate's favor before the approval hearing.

The second is whether $535 million is a reasonable price. Once ownership is settled, the bankruptcy court asks whether the compromise falls within a range of reasonableness, weighing the probability of success, collection risk, the complexity and expense of litigation, and creditors' interests. Claimants' valuations in the billions go to this question, but they do not change who gets to decide.

By denying the committee standing, Judge Kaplan kept both questions in the debtor's hands: the estate owns the claims, and the estate's compromise of them is reasonable.

What did the Third Circuit decide in In re Whittaker Clark & Daniels?

The Third Circuit held that the successor liability claims talc creditors sought to assert against Brenntag are property of the Whittaker bankruptcy estates under 11 U.S.C. § 541(a)(1), so only the debtor can pursue or settle them. It also held that Whittaker's board had authority to file for bankruptcy even though a South Carolina court had appointed a receiver over the company.

The court first ruled on September 10, 2025 (In re Whittaker Clark & Daniels, Inc., 152 F.4th 432). It then granted panel rehearing and, on April 27, 2026, issued an amended precedential opinion reaching the same result, reported at 176 F.4th 241; rehearing en banc was denied. The amended opinion affirmed the bankruptcy court's 2024 summary-judgment ruling (reported at 663 B.R. 1) that the claims are estate property.

The panel built on In re Emoral, Inc., 740 F.3d 875 (3d Cir. 2014), which held that personal injury plaintiffs' successor liability claims against the buyer of a bankrupt company's assets were "general" claims belonging to the estate because they depended on the debtor's relationship with the buyer rather than on any injury unique to an individual plaintiff. The Third Circuit treated the committee's product-line theory the same way, reasoning that it turns on the successor's relationship with the manufacturer. Law-firm commentary on the amended opinion notes that the court declined to require that the debtor itself be able to assert the claim under state law before it can be estate property.

Can talc claimants still sue Brenntag or Berkshire Hathaway?

Not on general successor liability theories. Under the Third Circuit's ruling and the approval order, claims that Brenntag or National Indemnity is liable simply because it succeeded to Whittaker's business belong to the estate and are released by the settlement, and the bankruptcy court refused to grant the claimants' committee standing to pursue them.

What remains less settled is the treatment of individualized theories. Commentary on the Third Circuit opinion reads it as leaving room for a creditor to sue a third party for an injury that is personal to that creditor, for example based on the third party's own conduct, rather than derivative of the debtor's relationship with the buyer. Plaintiffs' lawyers holding Whittaker talc cases will need to sort their clients' theories against Brenntag into those two buckets, and expect any individualized claim to draw a stay or release argument from the defendants.

The environmental settlement approved alongside

The same order approved a separate environmental settlement, Law360 reported. That deal, valued at $16.5 million in Law360's August 2026 coverage, was defended by the EPA together with California and Montana against an objection from a group of personal injury creditors. According to Mealey's, it transfers the Lockwood Solvent Superfund site to a trust benefiting the EPA and Montana. The EPA describes the Lockwood Solvent Ground Water Plume as a 580-acre site on the outskirts of Billings in Yellowstone County, Montana; Soco West, one of the debtors, had earlier agreed under a 2011 consent decree to clean up its portion. Resolving the government's claims removes the EPA objection that had targeted the $535 million deal's environmental liability assumptions.

Timeline: from a 2004 asset sale to a 2026 approval

Date	Event
2004	Whittaker and affiliates sell operating assets to Brenntag for $200 million; Brenntag does not assume asbestos or environmental liabilities
2007	National Indemnity (Berkshire Hathaway) acquires Brenntag's stock ownership of the Whittaker entities and, via indemnities, backstops asbestos successor claims against Brenntag
2016–2023	Whittaker loses mesothelioma trials including Depoian ($18.07M, Los Angeles) and Plant ($29.14M, South Carolina)
Apr. 26, 2023	Whittaker and three affiliates file Chapter 11 in the District of New Jersey facing more than 2,700 talc claims
2024	Bankruptcy court holds successor liability claims are estate property (663 B.R. 1); Whittaker moves to approve the $535 million settlement
Early 2025	EPA objects that the deal undervalues environmental liabilities
Sept. 10, 2025	Third Circuit affirms (152 F.4th 432)
Apr. 27, 2026	Third Circuit issues amended opinion on rehearing, same result (176 F.4th 241)
July–Sept. 2026	Receiver Peter Protopapas and the talc committee file certiorari petitions (Nos. 26-129, 26-159, 26-263)
Aug. 2026	EPA, California and Montana defend $16.5 million environmental settlement
Oct. 22, 2026	Chief Judge Kaplan approves the $535 million settlement and environmental settlement; denies committee standing

Will the Whittaker settlement be appealed?

Yes. An attorney for the claimants told Reuters she plans to appeal the approval. An appeal from the bankruptcy court ordinarily goes to the U.S. District Court for the District of New Jersey, although parties can seek certification for a direct appeal to the Third Circuit, as happened with the 2024 estate-property ruling.

The appeal will run alongside three certiorari petitions already at the Supreme Court. Peter Protopapas, the South Carolina court-appointed receiver, filed No. 26-129, arguing the Third Circuit wrongly rejected a Rooker-Feldman challenge to the bankruptcy court's jurisdiction, and a second petition, No. 26-159. The Official Committee of Talc Claimants, after obtaining an extension from Justice Alito (Application No. 26A86), filed No. 26-263 on August 25, 2026, arguing that other circuits hold a claim can be estate property only if the debtor itself could assert it under state law. Amicus filings referencing No. 26-263 were circulating by mid-October. No ruling on any of the petitions had been reported when Judge Kaplan approved the deal.

If the Supreme Court took the committee's case and reversed on the estate-property question, the legal premise of the settlement, that Whittaker alone could release the Brenntag claims, would be in doubt. That is the single largest risk to the deal's finality.

When will Whittaker talc claimants get paid?

No payment date has been announced. The $535 million is paid to the estate and is expected to fund distributions under Whittaker's Chapter 11 plan, which must still be confirmed; individual claimants will be paid only under that plan's claims procedures. A pending appeal of the approval order, and the pending Supreme Court petitions, could delay funding if a court stays the order. Claimants should expect any distribution to follow plan confirmation, not the approval ruling itself.

What it means for the bar and for mass tort bankruptcies

For mesothelioma and talc plaintiffs' firms: Successor liability, once a reliable route to a solvent defendant when a supplier went under, is now largely controlled by the debtor in the Third Circuit when the theory is "general." Firms with Whittaker talc clients should audit pending state-court complaints against Brenntag for theories that could be framed as individualized, track the plan's trust distribution procedures, and preserve exposure and product identification evidence for the claims process.

For successors and their insurers: The Whittaker sequence (asset sale without assumption of liabilities, later indemnity backstop, then a Chapter 11 of the shell seller) shows a non-debtor buyer and its insurer can obtain a release of successor exposure through an estate settlement, without themselves filing for bankruptcy and without the consensual-release limits that Purdue Pharma imposes on plan releases. Expect other asbestos-era asset buyers to study the structure.

For mass tort bankruptcy strategy: Whittaker is a different tool from the Texas Two-Step used by J&J and other solvent defendants: here the debtor really was defunct and the fight was over its claims against others. But both lines of cases ask the same policy question, whether bankruptcy can cap the tort exposure of solvent companies that stand behind a debtor. A grant of certiorari in No. 26-263 would put the estate-property half of that question squarely before the Court.

For future claimants: A future claimants' representative joined the committee's standing motion, a signal that people not yet diagnosed with talc-related mesothelioma are, in the representative's view, also undercompensated by the deal. Their recovery will depend on how the plan reserves funds for later-diagnosed disease.

FAQ

What is the Whittaker Clark & Daniels talc settlement?

It is a $535 million agreement, approved on October 22, 2026 by Chief Judge Michael B. Kaplan of the U.S. Bankruptcy Court for the District of New Jersey, under which Brenntag, DB US Holding Corp. and Berkshire Hathaway's National Indemnity pay the bankrupt talc supplier's estate in exchange for releases of successor liability and related claims.

Who is paying the $535 million?

Whittaker's former corporate affiliates: Brenntag, which bought Whittaker's operating assets in 2004, DB US Holding Corp., and Berkshire Hathaway group companies led by National Indemnity, which acquired the Whittaker entities in 2007 and backstops asbestos claims against Brenntag.

Can talc victims still sue Brenntag or National Indemnity?

Not on general successor liability theories; the Third Circuit held those claims belong to Whittaker's estate, and the approved settlement releases them. Claims based on an injury personal to a specific plaintiff stand on different footing, but none has been tested against the new order.

Is the Whittaker settlement final?

No. Claimants' counsel has said she will appeal, and certiorari petitions in Nos. 26-129, 26-159 and 26-263 challenging the Third Circuit's Whittaker rulings were pending at the Supreme Court with no reported disposition.

How many people have claims against Whittaker?

More than 2,700 people had filed claims alleging asbestos-contaminated Whittaker talc caused their cancer when the company filed for Chapter 11 on April 26, 2023, and future claimants are represented separately by a court-appointed representative.